Alliance Foundation Trials LLC

3 trials 1 recruiting Academic / non-commercial

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

12 Countries active

11 Unique IMPs

100% Results reported

Phase III

Oversight events:

1 serious breach across 1 trial

View oversight register →

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

BRCA1 gene mutation 1 Prophylaxis 1 Breast cancer 1

Top IMPs

PALBOCICLIB 2 DENOSUMAB 1

All trials

3 total

BRCA-P: A Cancer Prevention study to determine if Denosumab can prevent Breast Cancer Development in Women carrying a BRCA1 Germline Mutatio… Recruiting

2024-513734-38-00 Phase III 3 countries DENOSUMAB
Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-… Ended

2024-513540-29-00 Phase III 5 countries PALBOCICLIB
PALLAS - PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy vers… Ended

2024-514841-12-00 Phase III 11 countries PALBOCICLIB

Showing 1–3 of 3 trials

← All sponsors A–Z